These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31617449)

  • 1. Safety and Efficacy of Brivaracetam in Pediatric Refractory Epilepsy: A Single-Center Clinical Experience.
    McGuire S; Silva G; Lal D; Khurana DS; Legido A; Hasbani D; Carvalho KS; Melvin J; Valencia I
    J Child Neurol; 2020 Feb; 35(2):102-105. PubMed ID: 31617449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with brivaracetam in children - The experience of a pediatric epilepsy center.
    Nissenkorn A; Tzadok M; Bar-Yosef O; Ben-Zeev B
    Epilepsy Behav; 2019 Dec; 101(Pt A):106541. PubMed ID: 31698260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial.
    O'Brien TJ; Borghs S; He QJ; Schulz AL; Yates S; Biton V
    Epilepsia; 2020 Apr; 61(4):636-646. PubMed ID: 32221987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brivaracetam: First Canadian Experience in an Intractable Epilepsy Population.
    Lafortune J; Deacon C; Clément JF
    Can J Neurol Sci; 2020 Mar; 47(2):183-188. PubMed ID: 31685045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.
    Ortiz de la Rosa JS; Ladino LD; Rodríguez PJ; Rueda MC; Polanía JP; Castañeda AC
    Seizure; 2018 Mar; 56():34-40. PubMed ID: 29428899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice.
    Villanueva V; López-González FJ; Mauri JA; Rodriguez-Uranga J; Olivé-Gadea M; Montoya J; Ruiz-Giménez J; Zurita J;
    Acta Neurol Scand; 2019 Apr; 139(4):360-368. PubMed ID: 30506559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Tolerability of Lacosamide in the Treatment of Children With Refractory Generalized Epilepsy.
    Miskin C; Khurana DS; Valencia I; Legido A; Hasbani DM; Carvalho KS
    J Child Neurol; 2016 Jun; 31(7):925-8. PubMed ID: 26887412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial.
    Liu E; Dilley D; McDonough B; Stockis A; Daniels T
    Paediatr Drugs; 2019 Aug; 21(4):291-301. PubMed ID: 31250322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies.
    Moseley BD; Sperling MR; Asadi-Pooya AA; Diaz A; Elmouft S; Schiemann J; Whitesides J
    Epilepsy Res; 2016 Nov; 127():179-185. PubMed ID: 27608437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
    Strzelczyk A; Klein KM; Willems LM; Rosenow F; Bauer S
    Expert Rev Clin Pharmacol; 2016; 9(5):637-45. PubMed ID: 26891946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural changes in patients with intellectual disability treated with brivaracetam.
    Andres E; Kerling F; Hamer H; Winterholler M
    Acta Neurol Scand; 2018 Sep; 138(3):195-202. PubMed ID: 29658982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluation.
    Adewusi J; Burness C; Ellawela S; Emsley H; Hughes R; Lawthom C; Maguire M; McLean B; Mohanraj R; Oto M; Singhal S; Reuber M
    Epilepsy Behav; 2020 May; 106():106967. PubMed ID: 32179501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy.
    Ishikawa N; Tateishi Y; Tani H; Kobayashi Y; Kobayashi M
    Epilepsy Behav; 2019 May; 94():82-86. PubMed ID: 30897534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
    Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of brivaracetam in pediatric epilepsy.
    Verrotti A; Grasso EA; Cacciatore M; Matricardi S; Striano P
    Acta Neurol Scand; 2021 Jan; 143(1):19-26. PubMed ID: 32966640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, retention, and safety of brivaracetam in adult patients with genetic generalized epilepsy.
    Fonseca E; Guzmán L; Quintana M; Abraira L; Santamarina E; Salas-Puig X; Toledo M
    Epilepsy Behav; 2020 Jan; 102():106657. PubMed ID: 31731108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exceptional response to brivaracetam in a patient with refractory idiopathic generalized epilepsy and absence seizures.
    Grande-Martín A; Sopelana-Garay D; Pardal-Fernández JM; Sánchez-Honrubia RM; Sánchez-Larsen ÁA
    Epileptic Disord; 2018 Feb; 20(1):60-64. PubMed ID: 29160210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study.
    Toupin JF; Lortie A; Major P; Diadori P; Vanasse M; Rossignol E; D'Anjou G; Perreault S; Larbrisseau A; Carmant L; Birca A
    Epileptic Disord; 2015 Dec; 17(4):436-43. PubMed ID: 26609635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.